Cellular Biomedicine Losses Up $CBMG $XHS

Cellular Biomedicine Group Inc., has announced its first quarter results of FY-2015. The results shows Revenues were $603,390 compared to $61,051 YoY, while Net Loss spread to $4.3 million from $446,531. View the full earnings release here.